Alopecia With Endocrine Therapies in Patients With Cancer
Open Access
- 13 September 2013
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 18 (10), 1126-1134
- https://doi.org/10.1634/theoncologist.2013-0193
Abstract
Learning Objectives: Define the incidence and grades of alopecia to endocrine-based therapies in cancer patients. Differentiate risk of alopecia to various endocrine agents used against cancer. Design therapeutic, counseling, and supportive care strategies for patients requiring endocrine agents causing alopecia.Keywords
Funding Information
- RJR Oncodermatology Fund
This publication has 55 references indexed in Scilit:
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomographyBritish Journal of Dermatology, 2012
- Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II StudyClinical Cancer Research, 2011
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupJournal of Clinical Oncology, 2008
- Letrozole in advanced breast cancer: the PO25 trialBreast Cancer Research and Treatment, 2007
- Estrogen Carcinogenesis in Breast CancerThe New England Journal of Medicine, 2006
- Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational studyEuropean Journal of Cancer, 1997
- Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinomaEuropean Journal of Cancer, 1994
- Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinomaEuropean Journal of Cancer, 1993
- Prevention of Doxorubicin-Induced Hair Loss with Scalp HypothermiaThe New England Journal of Medicine, 1979
- Tamoxifen in Malignant MelanomaThe New England Journal of Medicine, 1979